Losartan as Anti-inflammatory Therapy to Augment F508del Cystic Fibrosis Transmembrane (CFTR) Recovery
Phase of Trial: Phase II
Latest Information Update: 20 Sep 2018
At a glance
- Drugs Losartan (Primary)
- Indications Cystic fibrosis
- Focus Proof of concept; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 21 Nov 2017 Status changed from not yet recruiting to recruiting.
- 06 Sep 2017 Planned initiation date changed from 20 Aug 2017 to 20 Apr 2018.